UBS O'Connor’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

UBS O'Connor’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-130,197	Closed	-$9.76M	–	643
2015 Q3	$9.76M	Buy	+130,197	New	+$9.72M	0.09%	227
2015 Q2	–	Sell	-50,278	Closed	-$2.52M	–	1034
2015 Q1	$2.52M	Buy	+50,278	New	+$2.11M	0.02%	371

UBS O'Connor's KYTH Position: Q4 2015 in Review

UBS O'Connor sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 130,197 shares — an estimated $9.76M sold.

UBS O'Connor first reported a position in KYTH in Q1 2015 and held it in 2 quarters. The position peaked at $9.76M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

UBS O'Connor reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
UBS O'Connor sold 130,197 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $9.76M.
UBS O'Connor first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q1 2015 and held it in 2 quarters.
UBS O'Connor's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $9.76M in Q3 2015.
0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on UBS O'Connor's 13F filing for Q4 2015, filed 10 Feb 2016.